Skip to main content

Main menu

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers

User menu

  • My alerts

Search

  • Advanced search
Annals of Family Medicine
  • My alerts
Annals of Family Medicine

Advanced Search

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers
  • Follow annalsfm on Twitter
  • Visit annalsfm on Facebook
Meeting ReportMusculoskeletal and rheumatology

Identifying clinically relevant subgroups of patients with knee pain flare-ups for ibuprofen treatment

Upasna Sharma, Jos Runhaar, P.K. Bos, Desiree Dorleijn, Marijn Vis, Patrick Bindels and Sita Bierma-Zeinstra
The Annals of Family Medicine November 2023, 21 (Supplement 3) 4794; DOI: https://doi.org/10.1370/afm.22.s1.4794
Upasna Sharma
MD, MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jos Runhaar
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P.K. Bos
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Desiree Dorleijn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marijn Vis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Bindels
MD, PhD, Prof
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sita Bierma-Zeinstra
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Abstract

Context Symptom flare-ups in knee osteoarthritis (OA) are associated with progression of OA, through worsening of synovitis. The randomised controlled trial (RCT) ‘Flaring Arthralgia Relief Evaluation in episodic flaring knee pain’ (FLARE) has shown no clinical benefit of a higher dose non-steroidal anti-inflammatory drugs (NSAIDs) over a lower dose, among individuals with a flare-up of knee pain.

Objective To identify potential subgroups of patients with a knee pain flare-up who benefit from a high dose NSAIDs treatment.

Study Design and Analysis This is a secondary explorative data analysis of a previous performed RCT (FLARE). A multilevel regression analysis was performed to estimate the magnitude of the effect of ibuprofen treatment in the different subgroups and to assess interaction effects.

Setting/Dataset The FLARE study was conducted at 27 primary care centers, located in the United Kingdom and the Netherlands. From this dataset we selected patients treated with a total daily dose of 1200mg or 2400mg for 5 days, with a value of pain severity on the numerical rating scale (NRS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score at least at baseline and end of treatment.

Population Studied Adults with a history of ≥1 knee pain flare episodes in the previous year (with or without treatment) and attending a baseline evaluation within 24 hours after experiencing a new episode (defined as pain severity ≥5 on a 0–10 NRS).

Intervention Subgroups (severity of morning stiffness, swelling, and pain) have been defined based on literature and clinical expertise.

Outcome Measures The primary outcome was the difference in pain severity after full treatment. Difference in WOMAC pain subscale after 5 days and in pain severity after 3 days were secondary outcomes.

Results The cohort (n=308) existed of a population with a mean age of 52.4±12.9 (SD) years and 41% females. No significant interaction was found between the predefined subgroups and the treatment effect on pain severity after day 5 (p-values ≥0.28) or on the secondary outcomes (all p-values ≥0.17). Given the potential lack of power, the absolute and adjusted mean differences between treatment arms were compared for each subgroup; none of the differences reached clinical significance.

Conclusion Ibuprofen 2400mg had no significant or clinical beneficial effect compared to 1200mg among the predefined subgroups of patients with indications for knee joint inflammation.

  • © 2023 Annals of Family Medicine, Inc.
Previous
Back to top

In this issue

The Annals of Family Medicine: 21 (Supplement 3)
The Annals of Family Medicine: 21 (Supplement 3)
Vol. 21, Issue Supplement 3
1 Nov 2023
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Annals of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Identifying clinically relevant subgroups of patients with knee pain flare-ups for ibuprofen treatment
(Your Name) has sent you a message from Annals of Family Medicine
(Your Name) thought you would like to see the Annals of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 16 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Identifying clinically relevant subgroups of patients with knee pain flare-ups for ibuprofen treatment
Upasna Sharma, Jos Runhaar, P.K. Bos, Desiree Dorleijn, Marijn Vis, Patrick Bindels, Sita Bierma-Zeinstra
The Annals of Family Medicine Nov 2023, 21 (Supplement 3) 4794; DOI: 10.1370/afm.22.s1.4794

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Get Permissions
Share
Identifying clinically relevant subgroups of patients with knee pain flare-ups for ibuprofen treatment
Upasna Sharma, Jos Runhaar, P.K. Bos, Desiree Dorleijn, Marijn Vis, Patrick Bindels, Sita Bierma-Zeinstra
The Annals of Family Medicine Nov 2023, 21 (Supplement 3) 4794; DOI: 10.1370/afm.22.s1.4794
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Project ECHO Rheumatology – Rationale and Results from a Multi-Method Study to Capture Impact
  • Prolotherapy in the Academy: Results of a National Cross-Sectional Mixed Methods Survey
  • Effect of vitamin D supplementation on patients with low back pain; A systematic review
Show more Musculoskeletal and rheumatology

Similar Articles

Content

  • Current Issue
  • Past Issues
  • Early Access
  • Plain-Language Summaries
  • Multimedia
  • Podcast
  • Articles by Type
  • Articles by Subject
  • Supplements
  • Calls for Papers

Info for

  • Authors
  • Reviewers
  • Job Seekers
  • Media

Engage

  • E-mail Alerts
  • e-Letters (Comments)
  • RSS
  • Journal Club
  • Submit a Manuscript
  • Subscribe
  • Family Medicine Careers

About

  • About Us
  • Editorial Board & Staff
  • Sponsoring Organizations
  • Copyrights & Permissions
  • Contact Us
  • eLetter/Comments Policy

© 2025 Annals of Family Medicine